Concourse Financial Group Securities, Inc. Collegium Pharmaceutical, Inc Transaction History

Concourse Financial Group Securities, Inc.

$1.56 Billion
Q2 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$31.36 - $39.99 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	BUY	$31.23 - $40.91 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	SELL	$21.16 - $30.8 $126 - $184	-6 Closed	0 $0
Q3 2023 Oct 25, 2023	SELL	$21.23 - $24.28 $42 - $48	-2 Reduced 25.0%	6 $0
Q2 2023 Aug 10, 2023	SELL	$21.06 - $24.0 $93,064 - $106,056	-4,419 Reduced 99.82%	8 $0
Q1 2023 May 15, 2023	BUY	$23.0 - $29.88 $101,821 - $132,278	4,427 New	4,427 $106,000
Q4 2022 Jan 30, 2023	BUY	$16.14 - $23.55 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$15.46 - $20.1 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$14.22 - $20.88 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$17.2 - $22.5 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	SELL	$17.5 - $21.35 $8,592 - $10,482	-491 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$17.75 - $25.39 $1,881 - $2,691	106 Added 27.53%	491 $10,000
Q2 2021 Aug 13, 2021	BUY	$21.74 - $25.28 $2,913 - $3,387	134 Added 53.39%	385 $9,000
Q1 2021 May 13, 2021	BUY	$19.25 - $26.1 $1,058 - $1,435	55 Added 28.06%	251 $6,000
Q3 2020 Nov 13, 2020	SELL	$15.78 - $20.82 $94 - $124	-6 Reduced 2.97%	196 $4,000
Q2 2020 Aug 13, 2020	BUY	$15.49 - $23.51 $1,006 - $1,528	65 Added 47.45%	202 $4,000
Q4 2019 Feb 14, 2020	BUY	$10.7 - $22.24 $1,465 - $3,046	137 New	137 $3,000
Q3 2019 Nov 13, 2019	BUY	$10.16 - $13.28 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$10.62 - $16.59 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	BUY	$13.58 - $18.72 $0 - $0	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	$14.78 - $19.68 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$14.16 - $24.3 $0 - $0	0 New	0 $0

Others Institutions Holding COLL

# of Institutions

236

Shares Held

39.4M

Call Options Held

84.2K

Put Options Held

18.6K

Black Rock Inc. New York, NY

5.79M
Shares

$226 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

3.41M
Shares

$133 Million
0.28% of portfolio
Eventide Asset Management, LLC Boston, MA

2.63M
Shares

$103 Million
1.49% of portfolio
Vanguard Group Inc Valley Forge, PA

2.37M
Shares

$92.3 Million
0.0% of portfolio
Rubric Capital Management LP New York, NY

2.33M
Shares

$90.8 Million
2.23% of portfolio

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.33B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account